Detalles de la búsqueda
1.
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
Hematol Oncol
; 38(3): 244-256, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32067259
2.
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Ann Hematol
; 98(4): 897-907, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610279
3.
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO).
Cancers (Basel)
; 14(6)2022 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326695
4.
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial.
Hemasphere
; 6(12): e808, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479544
5.
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
Hemasphere
; 5(7): e600, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34179697
6.
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).
J Cancer Res Clin Oncol
; 146(3): 749-759, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31788741
7.
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapy.
Cancer Med
; 9(22): 8386-8396, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32926763
8.
Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.
Clin Lymphoma Myeloma Leuk
; 18(4): 266-271, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29510895
9.
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
J Clin Oncol
; 36(20): 2024-2034, 2018 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29750632
10.
Hip pain in medulloblastoma as first symptom of extraneural relapse.
Onkologie
; 34(4): 196-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21447979
11.
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients.
Blood
; 111(4): 1855-61, 2008 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18056840
12.
Successful combination of anti-CD33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia.
Br J Haematol
; 120(6): 1093-4, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12648086
Resultados
1 -
12
de 12
1
Próxima >
>>